Get started
Author

Christina Michael

Observed name: Michael, Christina
ORCID: 0000-0003-1081-6807
Observed ORCID: 0000-0003-1081-6807
OpenAlex ID: A5088282910
Polymeric micelles effectively reprogram the tumor microenvironment to potentiate nano-immunotherapy in mouse breast cancer models
2022 · Myrofora Panagi, Fotios Mpekris, et al. · Nature Communications · 120
PDF
Metabolic output defines Escherichia coli as a health-promoting microbe against intestinal Pseudomonas aeruginosa
2019 · Theodoulakis Christofi, Stavria Panayidou, et al. · Scientific Reports · 58
PDF
Stabilizing Tumor-Resident Mast Cells Restores T-Cell Infiltration and Sensitizes Sarcomas to PD-L1 Inhibition
2024 · Myrofora Panagi, Fotios Mpekris, et al. · Clinical Cancer Research · 51
PDF
Ultrasound stiffness and perfusion markers correlate with tumor volume responses to immunotherapy
2023 · Chrysovalantis Voutouri, Fotios Mpekris, et al. · Acta Biomaterialia · 51
Endothelin Inhibition Potentiates Cancer Immunotherapy Revealing Mechanical Biomarkers Predictive of Response
2021 · Chrysovalantis Voutouri, Myrofora Panagi, et al. · Advanced Therapeutics · 41
PDF
Pirfenidone-Loaded Polymeric Micelles as an Effective Mechanotherapeutic to Potentiate Immunotherapy in Mouse Tumor Models
2023 · Fotios Mpekris, Petri Ch. Papaphilippou, et al. · ACS Nano · 37
Mechanical forces inducing oxaliplatin resistance in pancreatic cancer can be targeted by autophagy inhibition
2024 · Maria Kalli, Fotios Mpekris, et al. · Communications Biology · 36
Histone N-terminal acetyltransferase NAA40 links one-carbon metabolism to chemoresistance
2021 · Christina Demetriadou, Anastasia Raoukka, et al. · Oncogene · 29
PDF
Translational nanomedicine potentiates immunotherapy in sarcoma by normalizing the microenvironment
2022 · Fotios Mpekris, Myrofora Panagi, et al. · Journal of Controlled Release · 24
A synergistic approach for modulating the tumor microenvironment to enhance nano-immunotherapy in sarcomas
2024 · Fotios Mpekris, Myrofora Panagi, et al. · Neoplasia · 20
Tumor Microenvironment Reprogramming Improves Nanomedicine-Based Chemo-Immunotherapy in Sarcomas
2024 · Antonia Charalambous, Fotios Mpekris, et al. · Molecular Cancer Therapeutics · 17
Proteobacteria and Firmicutes Secreted Factors Exert Distinct Effects on Pseudomonas aeruginosa Infection under Normoxia or Mild Hypoxia
2022 · Anna Charalambous, Evangelos Grivogiannis, et al. · Metabolites · 10
PDF
Color-Tunable, White Light Emission from Electrospun Nanocomposite Fibers Sensitized by Graphene Quantum Dots
2025 · Georgia Papaparaskeva, Paris Papagiorgis, et al. · ACS Applied Optical Materials · 6
Abstract 6382: Targeting mast cells restores T cell infiltration and sensitizes sarcomas to PD-L1 inhibition
2022 · Myrofora Panagi, Fotios Mpekris, et al. · Cancer Research · 5
Oct4 is a gatekeeper of epithelial identity by regulating cytoskeletal organization in skin keratinocytes
2024 · Elena D. Christofidou, Marios Tomazou, et al. · Cell Reports · 3
Endothelin Inhibition Potentiates Cancer Immunotherapy Revealing Mechanical Biomarkers Predictive of Response (Adv. Therap. 9/2021)
2021 · Chrysovalantis Voutouri, Myrofora Panagi, et al. · Advanced Therapeutics · 2
Synthetic Inducible Bacteria Normalize the Microenvironment of Refractory Tumors, Potentiating Checkpoint Inhibitor Responses
2026 · Myrofora Panagi, Fotios Mpekris, et al. · Molecular Cancer Therapeutics · 1
Data from Tumor Microenvironment Reprogramming Improves Nanomedicine-Based Chemo-Immunotherapy in Sarcomas
2024 · Antonia Charalambous, Fotios Mpekris, et al. · 1
Data from Stabilizing Tumor-Resident Mast Cells Restores T-Cell Infiltration and Sensitizes Sarcomas to PD-L1 Inhibition
2024 · Myrofora Panagi, Fotios Mpekris, et al. · 1
108 Prediction of cancer immunotherapy response using ultrasound imaging of tumor stiffness and perfusion
2022 · Chrysovalantis Voutouri, Triantafyllos Stylianopoulos, et al. · Journal for ImmunoTherapy of Cancer · 1
PDF
Supplementary Figure S8 from Synthetic Inducible Bacteria Normalize the Microenvironment of Refractory Tumors, Potentiating Checkpoint Inhibitor Responses
2026 · Myrofora Panagi, Fotios Mpekris, et al.
Supplementary Figure S3 from Synthetic Inducible Bacteria Normalize the Microenvironment of Refractory Tumors, Potentiating Checkpoint Inhibitor Responses
2026 · Myrofora Panagi, Fotios Mpekris, et al.
Supplementary Figure S5 from Synthetic Inducible Bacteria Normalize the Microenvironment of Refractory Tumors, Potentiating Checkpoint Inhibitor Responses
2026 · Myrofora Panagi, Fotios Mpekris, et al.
Supplementary Figure S4 from Synthetic Inducible Bacteria Normalize the Microenvironment of Refractory Tumors, Potentiating Checkpoint Inhibitor Responses
2026 · Myrofora Panagi, Fotios Mpekris, et al.
Data from Synthetic Inducible Bacteria Normalize the Microenvironment of Refractory Tumors, Potentiating Checkpoint Inhibitor Responses
2026 · Myrofora Panagi, Fotios Mpekris, et al.
Works count: 67
Citation count: 514
H-index: 11
I10-index: 12
Year
Topic
Type